Dr. Lea Watson covers two drugs, Nuplazid and the new one approved by the FDA, Aducanumab. Followed by Dr. Sing Palat, CMD and new President of CMDA who discusses the use of oxygen with nocturnal hypoxemia in COPD.
Recording Date: 5/6/2021
Available Credit
- 0.25 CMD-Clinical
Comments (3)
More Episodes
All Episodes>>
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
